Anonymization with Actionable Insight in Mind

When anonymizing data for the public domain in such a way that it retains scientific meaning and value, we provide information that is more easily understood and of greater benefit to stakeholders. As a leading provider of anonymization and redaction solutions for Clinical Trial data in the public domain, Synchrogenix has developed more Advanced Anonymization solutions with the ability to infer actionable insight in mind

Our Quantitative Risk Assessment methodology is based on internal expertise taking in to consideration guidance from PhUSE, Health Canada, EMA and other regional agencies.  

Submit the following form to speak with a representative about Advanced Anonymization.